Navigation Links
Measuring artery repair cells could become new heart disease test

A more accurate method for measuring blood levels of specialized cells that circulate in the bloodstream and repair damage to the arterial lining has been discovered by Duke University Medical Center cardiologists. These cells, known as endothelial progenitor cells (EPC), are produced in the bone marrow and travel to the site of arterial damage.

The researchers said that tests for EPCs could be used to assess a patient's degree of coronary artery disease or risks for suffering a heart attack, and they could become as routine as the cholesterol and lipid tests cardiologists now commonly use. Patients with lower levels of circulating EPCs would be less able to repair cardiac damage. Thus, they would be those with greater disease and at greater risk for a cardiac event, said the Duke cardiologists

Additionally, the researchers found that the EPC levels correlated with the degree of coronary artery disease. Patients with no coronary artery disease had about 70 percent more EPCs than those who had disease in several coronary vessels.

Recent Duke research has linked the progression of the artery-clogging disease atherosclerosis to the inability of EPCs to continuously repair damage to the arterial lining. Duke researchers have shown that -- while risk factors such as poor diet, smoking, high cholesterol levels and inactivity are important in the development of atherosclerosis --the disease progresses as the body's loses its intrinsic ability to repair and rejuvenate itself.

Current methods for measuring EPCs ?which can represent as few as one out of 10,000 cells in a given blood sample ?are subjective and time-consuming, the researchers said. As an indicator of EPC cell levels, the new method uses measurements of the amount of a detoxification enzyme, known as aldehyde dehydrogenase (ALDH), which is produced in high amounts by EPCs.

"Our studies have shown that using ALDH activity to determine the numbers of EPCs in a blood sample mi
'"/>

Source:Duke University Medical Center


Page: 1 2 3

Related biology news :

1. Measuring the impact of post-genomics on Mediterranean populations
2. Measuring hormone cuts antibiotic use in half in pneumonia patients
3. Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol
4. Measuring hidden parasites in falciparum malaria
5. Columbia study shows widely used artery clearing device does not help patients during heart attack
6. Heart repair gets new muscle
7. Nano-bumps could help repair clogged blood vessels
8. New understanding of DNA repair may pave way to cancer treatments
9. Researchers pioneer new gene therapy technique using natural repair process
10. Circulating stem cells play small role in lung repair
11. Muscle repair: Making a good system better, faster; implications for aging, disease

Post Your Comments:
(Date:11/24/2009)... may help gut bacteria bind to the gastrointestina...oducers to identify strains that are likely to be ...interact with cells lining the gut to have a benef...e gut they are more likely to stick around long en...ge from the Institute of Food Research. IFR is an...
(Date:11/24/2009)...l Toxicology (ACMT) have signed an agreement to co...dical Toxicology (JMT), the official journal of t...ly published by the University of Pennsylvania Pre...nternational, peer-reviewed journal, is dedicated ...oxicology. The quarterly journal focuses on the d...
(Date:11/24/2009)...debate. A high-profile study a few years ago sugge...on from trees and leaves, evidence for a very clos...ems. , But new research from the University of W...ae provide a much richer diet for fish and other a...week in the Proceedings of the National Academy o...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Omega 3s Benefit Heart Attack Survivors Healthy Adults Mothers and Infants 51086 1Omega 3s Benefit Heart Attack Survivors Healthy Adults Mothers and Infants 51086 2March of Dimes Names Two New Trustees 51084 1March of Dimes Names Two New Trustees 51084 2Forsyth Medical Center participating in Avastin trial for new glioblastoma patients 51082 1Forsyth Medical Center participating in Avastin trial for new glioblastoma patients 51082 2
... gene responsible for the production of a protein ... treating pancreatic cancer, suggests research pub...is the fifth leading cause of cancer deaths in the...eat. Only 3% of affected patients are still alive ...as remained static for the past three decades. , ...
...ale is a founding member of the Genome-Wide RNAi G... biomedical research centers formed to speed scien... the entire human genome. The initiative is sponso...t complete human genome siRNA library, or compilat...es. The library is designed to determine when indi...
...accines have helped eradicate and tame some of his...ny more diseases out there that vaccines can help ...t to unlock the future promise of vaccines against...a new report by the American Academy of Microbiolo...ase has been profound. Many diseases that formerl...
Other Biology News:Gene therapy potential for treatment of pancreatic cancer 2Yale participates in global human genome initiative 2Report focuses on challenges to unlocking future promise of vaccines 2
(Date:11/24/2009)...YKJAVIK,Iceland,November24/PRNewswire-FirstCall/--...heapprovalofallofits,"firstday"motionsbytheU.S.Ban...cyCourt").deCODElastweekfiledavoluntarypetitionfor...dewiththe,BankruptcyCourt. , Theordersissuedb...rateitsbusinessduringtheChapter11proceedings.Inpar...
(Date:11/24/2009)...ANGHAI,Nov.24/PRNewswire-Asia/--ShanghaiBiolaxyann...SFDA)hasapprovedthe,investigationalnewdrugapplicat...tiveinsulinformulationtotreatdiabetes.ThisIND,appr...tudy. , Diabetesisadisordercharacteristicofhi...fdiabetesoftenresultinseveremicro-and,macro-vascul...
(Date:11/24/2009)...imaryefficacyendpointhasbeenmetforpatientswithadva...EBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZenta...albiopharmaceuticalcompanyfocusedonendocrinetherap...maPhase2studywithitstargetedcytotoxicpeptideconjug...dorrecurrentendometrialcancer.Inapersonalizedhealt...
(Date:11/24/2009)...NDIEGO,Nov.24,2009/PRNewswire-FirstCall/--ArenaPha...atthecompanyisscheduledtopresentatthePiperJaffray2...30a.m.EasternTime(8:30a.m.PacificTime)attheNewYork...t andChiefExecutiveOfficer,isscheduledtoprovideano...tanddiscoveryprograms. ,, Aliveaudiowebcastofth...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Biolaxy Secures IND Approval for Oral Insulin 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...FRANCISCO, Calif., May 14 VaxGen,Inc. (OTC Bullet...y,provided guidance on its expected monthly cash e...g undertaken on April 9, 2008. VaxGen expects that...rd are unlikely to exceed,$1 million, made up of t... Company,s real estate and facility, estimated at ...
... May 14 Sigma-Aldrich (Nasdaq:,SIAL) announced to...nancial,Officer Michael R. Hogan will retire at a ...ed 55 in April, had notified the Company early thi...essor could be identified,and successfully transit...ify a successor from a pool of internal and extern...
...mer,s Study Group Outlines a National Plan, WASHI...ustice Sandra Day O,Connor and Former Speaker of t...ecial hearing of the U.S. Senate,Special Committee...hl,(D-WI) specifically to hear updates on the figh...Connor,s first public statement about her,commitme...
Other Biology Technology:Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 2Vaxgen Files 10-Q for First Quarter With SEC, Provides Future Burn Rate Guidance 3Sigma-Aldrich (Nasdaq: SIAL) CAO & CFO Hogan Plans to Retire; Search for Successor Underway 2Retired Supreme Court Justice Sandra Day O'Connor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimer's Disease 2Retired Supreme Court Justice Sandra Day O'Connor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimer's Disease 3
...system combines world-class performance hardware, ...ftware, Agilents world-renowned support and column...lies--a combination that lets you reach uncompromi...sed on dependable data. The Agilent 6820 GC system...
7890A GC from Agilent Technologies
RF-5301 Fluorescence Spectrophotometer from Shimadzu
Kit for BASE20/50 dual control unit KIT50EHTD from Wave Biotech now part of GE Healthcare
Biology Products: